Search

everythinglearnresearchcommunity

for

Search:↓

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Male cells need DHT to respond to testosterone, while female cells do not.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Finasteride slowly binds to 5-alpha-reductase, affecting enzyme stability and inhibitor potency.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Finasteride, a drug that changes testosterone to a different hormone, was studied and its effects over time were modeled successfully.